Foxa1 reduces lipid accumulation in human hepatocytes and is down-regulated in nonalcoholic fatty liver

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Moya, Marta ^a   Benet, Marta ^a,b   Guzmán, Carla ^a   Tolosa, Laia ^a   García Monzón, Carmelo ^b,c   Pareja, Eugenia ^a   Castell, José Vicente ^a,b,d   Jover, Ramiro ^a,b,d  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL UNIVERSITARIO SANTA CRISTINA   (Spain)

^d UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B100; FATTY ACID TRANSPORTER; FATTY ACID TRANSPORTER 2; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; MESSENGER RNA; PROTEIN KINASE C; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 1; FOXA1 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOB GENE; ARTICLE; CATABOLISM; CELL CULTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DGAT2 GENE; DOWN REGULATION; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; FOXA1 GENE; GENE; GENE OVEREXPRESSION; GENE TARGETING; GPAM GENE; HUMAN; HUMAN CELL; KETOGENESIS; LIPID STORAGE; LIPOGENESIS; LIPOLYSIS; LIVER CELL; MALE; MARKER GENE; MITOCHONDRIAL MEMBRANE POTENTIAL; MTP GENE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PEROXISOME; PROTEIN ANALYSIS; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; UPREGULATION; ADULT; AGED; ANIMAL; CELL STRAIN HEPG2; FATTY LIVER; FEMALE; GENETICS; LIPID METABOLISM; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PRIMARY CELL CULTURE;

RATTUS;

ADULT; AGED; ANIMALS; CELLS, CULTURED; DOWN-REGULATION; FATTY LIVER; FEMALE; HEP G2 CELLS; HEPATOCYTE NUCLEAR FACTOR 3-ALPHA; HEPATOCYTES; HUMANS; LIPID METABOLISM; MALE; MIDDLE AGED; PRIMARY CELL CULTURE; RATS; YOUNG ADULT;

EID: 84855430898     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030014     Document Type: Article

References (40)

1. Friedman JR, Kaestner KH, (2006) The Foxa family of transcription factors in development and metabolism. Cell Mol Life Sci 63: 2317-2328.
2. Zhang L, Rubins NE, Ahima RS, Greenbaum LE, Kaestner KH, (2005) Foxa2 integrates the transcriptional response of the hepatocyte to fasting. Cell Metab 2: 141-148.
3. Wolfrum C, Asilmaz E, Luca E, Friedman JM, Stoffel M, (2004) Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes. Nature 432: 1027-1032.
4. Wolfrum C, Stoffel M, (2006) Coactivation of Foxa2 through Pgc-1beta promotes liver fatty acid oxidation and triglyceride/VLDL secretion. Cell Metab 3: 99-110.
5. Bochkis IM, Rubins NE, White P, Furth EE, Friedman JR, et al. (2008) Hepatocyte-specific ablation of Foxa2 alters bile acid homeostasis and results in endoplasmic reticulum stress. Nat Med 14: 828-836.
6. Wolfrum C, Besser D, Luca E, Stoffel M, (2003) Insulin regulates the activity of forkhead transcription factor Hnf-3beta/Foxa-2 by Akt-mediated phosphorylation and nuclear/cytosolic localization. Proc Natl Acad Sci U S A 100: 11624-11629.
7. Howell JJ, Stoffel M, (2009) Nuclear export-independent inhibition of Foxa2 by insulin. J Biol Chem 284: 24816-24824.
8. Shen W, Scearce LM, Brestelli JE, Sund NJ, Kaestner KH, (2001) Foxa3 (hepatocyte nuclear factor 3gamma) is required for the regulation of hepatic GLUT2 expression and the maintenance of glucose homeostasis during a prolonged fast. J Biol Chem 276: 42812-42817.
9. Shih DQ, Navas MA, Kuwajima S, Duncan SA, Stoffel M, (1999) Impaired glucose homeostasis and neonatal mortality in hepatocyte nuclear factor 3alpha-deficient mice. Proc Natl Acad Sci U S A 96: 10152-10157.
10. Vatamaniuk MZ, Gupta RK, Lantz KA, Doliba NM, Matschinsky FM, et al. (2006) Foxa1-deficient mice exhibit impaired insulin secretion due to uncoupled oxidative phosphorylation. Diabetes 55: 2730-2736.
11. Sund NJ, Ang SL, Sackett SD, Shen W, Daigle N, et al. (2000) Hepatocyte nuclear factor 3beta (Foxa2) is dispensable for maintaining the differentiated state of the adult hepatocyte. Mol Cell Biol 20: 5175-5183.
12. Kaestner KH, Hiemisch H, Schutz G, (1998) Targeted disruption of the gene encoding hepatocyte nuclear factor 3gamma results in reduced transcription of hepatocyte-specific genes. Mol Cell Biol 18: 4245-4251.
13. Moya M, Jose Gomez-Lechon M, Castell JV, Jover R, (2010) Enhanced steatosis by nuclear receptor ligands: A study in cultured human hepatocytes and hepatoma cells with a characterized nuclear receptor expression profile. Chem Biol Interact 184: 376-387.
14. Castell J, Hernandez D, Gomez F, AM, Guillen I, Donato T, et al. (1997) Adenovirus-mediated gene transfer into human hepatocytes: analysis of the biochemical functionality of transduced cells. Gene Ther 4: 455-464.
15. Ruyter B, Andersen O, Dehli A, Ostlund Farrants AK, Gjoen T, et al. (1997) Peroxisome proliferator activated receptors in Atlantic salmon (Salmo salar): effects on PPAR transcription and acyl-CoA oxidase activity in hepatocytes by peroxisome proliferators and fatty acids. Biochim Biophys Acta 1348: 331-338.
16. Small GM, Burdett K, Connock MJ, (1985) A sensitive spectrophotometric assay for peroxisomal acyl-CoA oxidase. Biochem J 227: 205-210.
17. Benet M, Lahoz A, Guzman C, Castell JV, Jover R, (2010) CCAAT/enhancer-binding protein alpha (C/EBPalpha) and hepatocyte nuclear factor 4alpha (HNF4alpha) synergistically cooperate with constitutive androstane receptor to transactivate the human cytochrome P450 2B6 (CYP2B6) gene: application to the development of a metabolically competent human hepatic cell model. J Biol Chem 285: 28457-28471.
18. Lai E, Prezioso VR, Tao WF, Chen WS, Darnell JE Jr, (1991) Hepatocyte nuclear factor 3 alpha belongs to a gene family in mammals that is homologous to the Drosophila homeotic gene fork head. Genes Dev 5: 416-427.
19. Lewis GF, (1997) Fatty acid regulation of very low density lipoprotein production. Curr Opin Lipidol 8: 146-153.
20. Gomez-Lechon MJ, Donato MT, Martinez-Romero A, Jimenez N, Castell JV, et al. (2007) A human hepatocellular in vitro model to investigate steatosis. Chem Biol Interact 165: 106-116.
21. Kampf JP, Kleinfeld AM, (2007) Is membrane transport of FFA mediated by lipid, protein, or both? An unknown protein mediates free fatty acid transport across the adipocyte plasma membrane. Physiology (Bethesda) 22: 7-14.
22. Ehehalt R, Fullekrug J, Pohl J, Ring A, Herrmann T, et al. (2006) Translocation of long chain fatty acids across the plasma membrane-lipid rafts and fatty acid transport proteins. Mol Cell Biochem 284: 135-140.
23. Falcon A, Doege H, Fluitt A, Tsang B, Watson N, et al. (2010) FATP2 is a hepatic fatty acid transporter and peroxisomal very long-chain acyl-CoA synthetase. Am J Physiol Endocrinol Metab 299: E384-393.
24. Reubsaet FA, Veerkamp JH, Bukkens SG, Trijbels JM, Monnens LA, (1988) Acyl-CoA oxidase activity and peroxisomal fatty acid oxidation in rat tissues. Biochim Biophys Acta 958: 434-442.
25. Del Mar Gonzalez-Barroso M, Ricquier D, Cassard-Doulcier AM, (2000) The human uncoupling protein-1 gene (UCP1): present status and perspectives in obesity research. Obes Rev 1: 61-72.
26. Lai E, Prezioso VR, Smith E, Litvin O, Costa RH, et al. (1990) HNF-3A, a hepatocyte-enriched transcription factor of novel structure is regulated transcriptionally. Genes Dev 4: 1427-1436.
27. Rausa FM, Tan Y, Zhou H, Yoo KW, Stolz DB, et al. (2000) Elevated levels of hepatocyte nuclear factor 3beta in mouse hepatocytes influence expression of genes involved in bile acid and glucose homeostasis. Mol Cell Biol 20: 8264-8282.
28. Hughes DE, Stolz DB, Yu S, Tan Y, Reddy JK, et al. (2003) Elevated hepatocyte levels of the Forkhead box A2 (HNF-3beta) transcription factor cause postnatal steatosis and mitochondrial damage. Hepatology 37: 1414-1424.
29. Tan Y, Hughes D, Wang X, Costa RH, (2002) Adenovirus-mediated increase in HNF-3beta or HNF-3alpha shows differences in levels of liver glycogen and gene expression. Hepatology 35: 30-39.
30. Choi CS, Savage DB, Kulkarni A, Yu XX, Liu ZX, et al. (2007) Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance. J Biol Chem 282: 22678-22688.
31. Yu XX, Murray SF, Pandey SK, Booten SL, Bao D, et al. (2005) Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice. Hepatology 42: 362-371.
32. Ishigaki Y, Katagiri H, Yamada T, Ogihara T, Imai J, et al. (2005) Dissipating excess energy stored in the liver is a potential treatment strategy for diabetes associated with obesity. Diabetes 54: 322-332.
33. Duncan SA, Navas MA, Dufort D, Rossant J, Stoffel M, (1998) Regulation of a transcription factor network required for differentiation and metabolism. Science 281: 692-695.
34. Pfaffl M, Hageleit M, (2001) Validities of mRNA quantification using recombinant RNA and recombinant DNA external calibration curves in real-time RT-PCR. Biotechnology Letters 23: 275-282.
35. Fabbrini E, Sullivan S, Klein S, (2010) Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology 51: 679-689.
36. Wang H, Wollheim CB, (2005) Does chasing selected 'Fox' to the nucleus prevent diabetes? Trends Mol Med 11: 262-265.
37. Postic C, Girard J, (2008) Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J Clin Invest 118: 829-838.
38. Samuel VT, Liu ZX, Wang A, Beddow SA, Geisler JG, et al. (2007) Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease. J Clin Invest 117: 739-745.
39. Wakusawa S, Ikeda R, Shiono Y, Hayashi H, (2001) Protein kinase C-mediated down-regulation of MDR3 mRNA expression in Chang liver cells. Biochem Pharmacol 61: 1339-1345.
40. Costanzo P, Lupo A, Medugno L, D'Agostino P, Zevino C, et al. (1999) PKC-dependent phosphorylation of the p97 repressor regulates the transcription of aldolase A L-type promoter. FEBS Lett 454: 61-66.